Q1 Earnings Estimate for SBC Issued By Sidoti Csr

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Analysts at Sidoti Csr issued their Q1 2027 earnings estimates for shares of SBC Medical Group in a research note issued on Wednesday, November 19th. Sidoti Csr analyst A. Shah forecasts that the company will post earnings of $0.14 per share for the quarter. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group’s Q2 2027 earnings at $0.14 EPS, Q3 2027 earnings at $0.15 EPS and FY2027 earnings at $0.59 EPS.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings results on Friday, November 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.01). The firm had revenue of $43.35 million during the quarter, compared to analysts’ expectations of $46.45 million. SBC Medical Group had a return on equity of 24.17% and a net margin of 24.28%.

A number of other equities research analysts have also recently commented on SBC. Wall Street Zen upgraded SBC Medical Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 20th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of SBC Medical Group in a research report on Monday, November 17th. Finally, Maxim Group started coverage on shares of SBC Medical Group in a research note on Wednesday, November 5th. They issued a “buy” rating and a $9.00 target price for the company. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $9.00.

SBC Medical Group Stock Up 6.4%

SBC Medical Group stock opened at $3.31 on Friday. SBC Medical Group has a 1-year low of $2.62 and a 1-year high of $7.99. The business has a fifty day moving average price of $3.85 and a 200-day moving average price of $4.22. The company has a debt-to-equity ratio of 0.07, a current ratio of 5.10 and a quick ratio of 3.95. The stock has a market capitalization of $343.84 million, a price-to-earnings ratio of 8.07 and a beta of 1.27.

Institutional Investors Weigh In On SBC Medical Group

Institutional investors and hedge funds have recently modified their holdings of the company. SBI Securities Co. Ltd. increased its holdings in SBC Medical Group by 227.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company’s stock worth $251,000 after buying an additional 37,623 shares during the period. Geode Capital Management LLC acquired a new stake in SBC Medical Group during the 2nd quarter valued at approximately $455,000. XTX Topco Ltd purchased a new stake in shares of SBC Medical Group in the 2nd quarter valued at $64,000. New York State Common Retirement Fund acquired a new stake in shares of SBC Medical Group in the second quarter worth $104,000. Finally, Millennium Management LLC acquired a new stake in shares of SBC Medical Group in the third quarter worth $219,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.